logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tanya Jindal

University System of Ohio
H指数:9
被引数:351

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with Immunotherapy

含免疫治疗的三期泌尿生殖系统癌症试验中非免疫治疗组的分配

Clinical Genitourinary Cancer
IF2.7
2026-01-010
PRE
Grier, Abby L.; Jang, Albert; Zhong, Jeffrey Y.; Kumar, Hamsa L. S.; Jindal, Tanya; Calaway, Adam; Jia, Angela Y.; Fu, Pingfu; Bukavina, Laura; Ghandour, Rashed; Shoag, Jonathan E.; Vince, Randy; Rao, Santosh; Sheng, Iris; Mendiratta, Prateek; Brown, Jason R.; Gupta, Shilpa; Garcia, Jorge A.; Barata, Pedro C.
EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer
The Oncologist
IF0
2025-12-310
OAAI
Albert Jang; Peggy Fowler; Kathryn Helminiak; Hamsa L S Kumar; Jeffrey Pasucal; Victoria Delong; Jeffrey Y Zhong; Tanya Jindal; Abby L Grier; Rishi R Patel; Mary Hislop; Alessandra Cesano; Karen Villaluna; Brett Younginger; Kayla Wolff; Kara Richey; Julie Bray; Hannah Garcia; Timothy Adamowicz; Amy Reese; Amanda Nizam; Shilpa Gupta; Christopher E Wee; Seunghee Margevicius; Pingfu Fu; Prateek Mendiratta; Iris Y Sheng; Jason R Brown; Jorge A Garcia; Pedro C Barata
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study

在恩沃利单抗之后的尿路上皮癌患者中，萨cituzumab govitecan的疗效：UNITE研究的分析

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
2025-12-010
OAAI
Jindal, Tanya; Jiang, Cindy Y.; Alhalabi, Omar; Davidsohn, Matthew; Freeman, Dory; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Nizam, Amanda; Nguyen, Charles B.; Oh, Eugene; Tsung, Irene; Glover, Michael J.; Khaki, Ali Raza; Taylor, Amy K.; Jaime-Casas, Salvador; Jang, Albert; Lemke, Emily; Pywell, Cameron; Evans, Sean T.; Shin, Denny; Bilen, Mehmet A.; Basu, Arnab; Kilari, Deepak; Tripathi, Abhishek; Brown, Jason; Emamekhoo, Hamid; Davis, Nancy B.; Shah, Sumit; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Alva, Ajjai; Campbell, Matthew T.; Koshkin, Vadim S.
Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617

PSMA阳性转移性去势抵抗性前列腺癌患者接受177Lu-PSMA-617治疗后的基因组改变及关联结局

ONCOLOGIST
IF4.2
2025-11-010
PRE
Panian, Justine; Henderson, Nicholas C.; Herchenhorn, Daniel; Barata, Pedro C.; Bilen, Mehmet Asim; Graham, Laura; Heath, Elisabeth; Hwang, Clara; Supernois, Avery; Kilari, Deepak; Thapa, Bicky; Koshkin, Vadim S.; Jindal, Tanya; Nauseef, Jones T.; Sokolova, Alexandra; Amery, Taylor; Zakharia, Yousef; Schweizer, Michael T.; Raychaudhuri, Ruben; Reichert, Zachery R.; Dorff, Tanya; Armstrong, Andrew J.; Wang, John; Alva, Ajjai; Mckay, Rana R.
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study

FGFR3突变型晚期尿路上皮癌中，erdafitinib在enfortumab vedotin治疗前或治疗后的疗效：UNITE协作研究的分析

ONCOLOGIST
IF4.2
2025-11-010
PRE
Jiang, Cindy Y.; Hwang, Hyunsoo; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Taylor, Amy K.; Nizam, Amanda; Jindal, Tanya; Glover, Michael J.; Khaki, Ali Raza; Barata, Pedro C.; Nguyen, Charles B.; Oh, Eugene; Davis, Nancy B.; Mabey, Hannah; Hoimes, Christopher J.; Evans, Sean T.; Abuqayas, Bashar; Lemke, Emily; Tsung, Irene; Qiao, Wei; Kilari, Deepak; Zakharia, Yousef; Bilen, Mehmet A.; Milowsky, Matthew, I; Shah, Sumit A.; Gupta, Shilpa; Emamekhoo, Hamid; Bellmunt, Joaquim; Alva, Ajjai S.; Grivas, Petros; Msaouel, Pavlos; Koshkin, Vadim S.; Campbell, Matthew T.; Alhalabi, Omar
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study

接受恩沃利单抗维多汀治疗的晚期尿路上皮癌患者中的治疗相关不良事件及关联结局：UNITE研究的分析

CANCER MEDICINE
IF3.1
2025-10-020
OAAI
Nizam, Amanda; Nguyen, Charles B.; Li, Jinju; Zabor, Emily C.; Msaouel, Pavlos; Jiang, Cindy Y.; Alhalabi, Omar; Oh, Eugene; Davidsohn, Matthew P.; Epstein, Ilana B.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Jindal, Tanya; Taylor, Amy K.; Glover, Michael J.; Khaki, Ali Raza; Lemke, Emily; Mabey, Hannah; Abuqayas, Bashar; Jang, Albert; Brown, Jason R.; Evans, Sean T.; Pywell, Cameron; Basu, Arnab; Bilen, Mehmet A.; Barata, Pedro C.; Zakharia, Yousef; Milowsky, Matthew I.; Kilari, Deepak; Hoimes, Christopher J.; Shah, Sumit A.; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Campbell, Matthew T.; Alva, Ajjai S.; Koshkin, Vadim S.
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study

恩福妥单抗（Enfortumab Vedotin）在具有不同组织学亚型的晚期尿路上皮癌患者中的疗效：UNITE研究的分析

European Urology
IF25.2
2025-09-140
PRE
Tanya Jindal; Cindy Y. Jiang; Omar Alhalabi; Charles B. Nguyen; Eugene Oh; Irene Tsung; Dimitra Rafailia Bakaloudi; Rafee Talukder; Matthew Davidsohn; Dory Freeman; Ilana Y. Epstein; Chien-Kuang Cornelia Ding; Amanda Nizam; Michael J. Glover; Ali Raza Khaki; Amy K. Taylor; Emily Lemke; Albert Jang; Sean T. Evans; Denny Shin; Cameron Pywell; Arnab Basu; Mehmet A. Bilen; Yousef Zakharia; Pedro Barata; Matthew I. Milowsky; Jason Brown; Deepak Kilari; Hamid Emamekhoo; Christopher J. Hoimes; Sumit Shah; Nancy B. Davis; Shilpa Gupta; Petros Grivas; Joaquim Bellmunt; Ajjai Alva; Matthew T. Campbell; Vadim S. Koshkin
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens

REFINE：接受基于免疫疗法治疗方案的肾细胞癌患者中，包含关联临床数据和基因组生物标志物的数据库

ONCOLOGIST
IF4.2
2025-06-010
OAAI
Zhong, Jeffrey; Jang, Albert; Abuqayas, Bashar; Basu, Arnab; Benjamin, David J.; Bhatlapenumarthi, Vineel; Bilen, Mehmet Asim; Buch, Dhvani; Chang, Mark; Chin, Erica; Darabi, Sourat; Dhanikonda, Nagendra; Ghatalia, Pooja; Grigg, Claud M.; Grier, Abby L.; Jindal, Tanya; Jung, Joannah; Kilari, Deepak; Kumar, Hamsa L. S.; Lee, Suzanna; Neelands, Brittany; Pandya, Chinmayi; Pawalek, Jeff; Staggers, Jaimee; Yildirim, Ahmet; Zakharia, Yousef; Zarrabi, Kevin K.; Zimmerman, Michael; Sledge, George; Spetzler, David; Elliott, Andrew; McKay, Rana R.; Barata, Pedro C.
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data

与恩夫妥单抗韦汀疗效相关的基因组生物标志物：对UNITE研究数据的分析

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-12-011
OAAI
Jindal, Tanya; Jiang, Cindy; Alhalabi, Omar; Nizam, Amanda; Nguyen, Charles; Talukder, Rafee; Bakaloudi, Dimitra; Davidsohn, Matthew; Freeman, Dory; Glover, Michael; Khaki, Ali Raza; Evans, Sean; Lemke, Emily; Bose, Rohit; Sim, Woogwang; Pywell, Cameron; Basu, Arnab; Kilari, Deepak; Barata, Pedro C.; Bilen, Mehmet A.; Zakharia, Yousef; Milowsky, Matthew I.; Shah, Sumit A.; Bellmunt, Joaquim; Grivas, Petros; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Hoimes, Christopher; Campbell, Matthew T.; Alva, Ajjai; Koshkin, Vadim S.
Efficacy of enfortumab vedotin (EV) in patients (pts) with (w) advanced urothelial carcinoma (aUC) who have baseline neuropathy (N) and/or diabetes mellitus (DM): A UNITE study analysis

恩诺妥昔单抗（EV）在具有基线神经病变（N）和/或糖尿病（DM）的晚期尿路上皮癌（aUC）患者（pts）中的疗效：一项UNITE研究的分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Jang, A.; Jindal, T.; Jiang, C. Y.; Nguyen, C. B.; Nizam, A.; Alva, A. S.; Grivas, P.; Bellmunt, J.; Hoimes, C. J.; Bilen, M. A.; Emamekhoo, H.; Milowsky, M. I.; Khaki, A. R.; Gupta, S.; Campbell, M. T.; Alhalabi, O.; Chen, Z.; Fu, P.; Koshkin, V. S.; Brown, J. R.
Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer

TP53和MDM2的体细胞改变与晚期尿路上皮癌患者对enfortumab vedotin的反应相关

FRONTIERS IN ONCOLOGY
IF3.3
2023-04-058
OAAI
Jindal, Tanya; Zhu, Xiaolin; Bose, Rohit; Kumar, Vipul; Maldonado, Edward; Deshmukh, Prianka; Shipp, Chase; Feng, Stephanie; Johnson, Michelle S.; Angelidakis, Austin; Kwon, Daniel; Borno, Hala T.; de Kouchkovsky, Ivan; Desai, Arpita; Aggarwal, Rahul; Fong, Lawrence; Small, Eric J.; Wong, Anthony; Porten, Sima; Chou, Jonathan; Friedlander, Terence; Koshkin, Vadim S.
APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer
FRONTIERS IN ONCOLOGY
IF3.3
2022-03-078
OAAI
Natesan, Divya; Zhang, Li; Martell, Henry J.; Jindal, Tanya; Devine, Patrick; Stohr, Bradley; Espinosa-Mendez, Carlos; Grenert, James; Van Ziffle, Jessica; Joseph, Nancy; Umetsu, Sarah; Onodera, Courtney; Turski, Michelle; Chan, Emily; Desai, Arpita; Aggarwal, Rahul; Wong, Anthony; Porten, Sima; Chou, Jonathan; Friedlander, Terence; Fong, Lawrence; Small, Eric J.; Sweet-Cordero, Alejandro; Koshkin, Vadim S.
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
CANCER
IF5.1
2021-12-0954
OAAI
Koshkin, Vadim S.; Henderson, Nicholas; James, Marihella; Natesan, Divya; Freeman, Dory; Nizam, Amanda; Su, Christopher T.; Khaki, Ali Raza; Osterman, Chelsea K.; Glover, Michael J.; Chiang, Ryan; Makrakis, Dimitrios; Talukder, Rafee; Lemke, Emily; Olsen, T. Anders; Jain, Jayanshu; Jang, Albert; Ali, Alicia; Jindal, Tanya; Chou, Jonathan; Friedlander, Terence W.; Hoimes, Christopher; Basu, Arnab; Zakharia, Yousef; Barata, Pedro C.; Bilen, Mehmet A.; Emamekhoo, Hamid; Davis, Nancy B.; Shah, Sumit A.; Milowsky, Matthew I.; Gupta, Shilpa; Campbell, Matthew T.; Grivas, Petros; Sonpavde, Guru P.; Kilari, Deepak; Alva, Ajjai S.

研究方向

暂未获取到该数据
V
Vadim S. Koshkin
H 指数:29论文数:280被引数:5,231
D
Deepak Kilari
H 指数:21论文数:212被引数:1,771
P
Pedro C. Barata
H 指数:33论文数:596被引数:4,637
M
Matthew T. Campbell
H 指数:33论文数:403被引数:8,302
A
Amanda Nizam
H 指数:12论文数:93被引数:1,006
Y
Yousef Zakharia
H 指数:39论文数:662被引数:7,491
H
Hamid Emamekhoo
H 指数:25论文数:212被引数:2,599
A
Ajjai Alva
H 指数:59论文数:458被引数:1.7万
M
Matthew I. Milowsky
H 指数:66论文数:575被引数:1.8万
M
Mehmet Asım Bilen
H 指数:49论文数:665被引数:1.1万